Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : CEAPRO INC.----CZO -- Ignore unavailable to you. Want to Upgrade?

To: haroldhecubah who wrote (33)	7/23/2020 3:45:23 PM
From: ciao888	Read Replies (1) \| Respond to of 53

Hi Harold, It's too bad that Ceapro remains non-promotional and goes about everything very business like and with no hype or fanfare. That was the concern that BNN analysts had with the company years ago. They missed out on a possible CBD angle with their PGX technology. Now with them working on a COVID treatment with McMaster University, if they could get the story out, the share price could easily be up a few fold. Examples of companies with preliminary work on treatments such as Synairgen have skyrocketed recently. Synairgen skyrockets Here we are with a market cap of $50M and a somewhat profitable company trading quietly on the TSXV.